The use of zanubrutinib in chronic lymphocytic leukemia.
Publication
, Journal Article
Brander, DM
Published in: Clin Adv Hematol Oncol
December 2022
Duke Scholars
Published In
Clin Adv Hematol Oncol
ISSN
1543-0790
Publication Date
December 2022
Volume
20
Issue
12
Start / End Page
705 / 708
Location
United States
Related Subject Headings
- Pyrimidines
- Pyrazoles
- Piperidines
- Oncology & Carcinogenesis
- Leukemia, Lymphocytic, Chronic, B-Cell
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Brander, D. M. (2022). The use of zanubrutinib in chronic lymphocytic leukemia. Clin Adv Hematol Oncol, 20(12), 705–708.
Brander, Danielle M. “The use of zanubrutinib in chronic lymphocytic leukemia.” Clin Adv Hematol Oncol 20, no. 12 (December 2022): 705–8.
Brander DM. The use of zanubrutinib in chronic lymphocytic leukemia. Clin Adv Hematol Oncol. 2022 Dec;20(12):705–8.
Brander, Danielle M. “The use of zanubrutinib in chronic lymphocytic leukemia.” Clin Adv Hematol Oncol, vol. 20, no. 12, Dec. 2022, pp. 705–08.
Brander DM. The use of zanubrutinib in chronic lymphocytic leukemia. Clin Adv Hematol Oncol. 2022 Dec;20(12):705–708.
Published In
Clin Adv Hematol Oncol
ISSN
1543-0790
Publication Date
December 2022
Volume
20
Issue
12
Start / End Page
705 / 708
Location
United States
Related Subject Headings
- Pyrimidines
- Pyrazoles
- Piperidines
- Oncology & Carcinogenesis
- Leukemia, Lymphocytic, Chronic, B-Cell
- Humans